Ismo (Isosorbide Mononitrate)

Isosorbide mononitrate is converted to nitric oxide after oral absorption. Nitric oxide activates guanylate cyclase, raising cyclic GMP levels in vascular smooth muscle. This biochemical cascade causes relaxation of arteries and veins, lowering preload and afterload, and ultimately decreasing myocardial oxygen demand while enhancing coronary blood flow.

The specific dose of Ismo is determined by the prescribing clinician based on the individual’s medical condition, response, and tolerability. Healthcare providers tailor the regimen to achieve optimal symptom control while minimizing side effects, and patients should follow the prescribed instructions exactly.

Safety data for isosorbide mononitrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare professional.

To request Ismo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ismo belongs to the nitrate class, offering long‑acting vasodilation, whereas other anti‑anginals such as beta‑blockers or calcium‑channel blockers act through different mechanisms like heart‑rate reduction or calcium antagonism. Nitrates are particularly effective for preventing exertional chest pain, but may cause headaches more frequently than some alternatives.

Ismo should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Ismo is taken orally, usually as a tablet, with or without food as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not crushed or chewed, unless the prescribing information specifically allows an alternative method.

The most serious risks include severe hypotension, syncope, and rare allergic reactions such as anaphylaxis or methemoglobinemia. Patients should seek immediate medical attention if they experience fainting, a sudden drop in blood pressure, or signs of a severe allergic response.

Ismo is contraindicated in patients with known hypersensitivity to isosorbide mononitrate or any nitrate, those who have taken phosphodiesterase‑5 inhibitors within the past 24‑48 hours, and individuals with severe hypotension or uncompensated heart failure unless specifically advised by a physician.